Phenotypic Variability in Monozygotic Twins with Neurofibromatosis 2

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 64, Issue 4, 1996, Pages 563-567

  Baser, Michael E ^a,d   Ragge, Nicola K ^a   Riccardi, Vincent M ^b   Janus, Todd ^c   Gantz, Bruce ^c   Pulst, Stefan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Neurofibromatosis Institute   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d NONE   (United States)

Author keywords

Neurofibromatosis 2; genes; Suppressor; Tumor; twins; phenotype

Indexed keywords

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BRAIN TUMOR; CASE REPORT; CATARACT; CHROMOSOME 22Q; FEMALE; GENE MUTATION; HUMAN; MALE; MONOZYGOTIC TWINS; NEURILEMOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR SUPPRESSOR GENE; VESTIBULAR DISORDER;

ADULT; CHILD; DISEASES IN TWINS; FEMALE; GENES, NEUROFIBROMATOSIS 2; HUMANS; INFANT; MALE; NEUROFIBROMATOSIS 2; PHENOTYPE;

EID: 0029795562     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960906)64:4<563::AID-AJMG7>3.0.CO;2-Q     Document Type: Article

References (42)

1. Baser ME, Mautner VF, Ragge NK, Nechiporuk A, Riccardi VM, Klein J, Sainz J, Pulst SM (1996): Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations. Neurology (in press).
2. Bourn D, Carter SA, Evans DGR, Goodship J, Coakham H, Strachan T (1994a): A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals. Am J Hum Genet 55:69-73.
3. Bourn D, Carter SA, Mason S, Evans DGR, Strachan T (1994b): Germline mutations in the neurofibromatosis 2 gene in multiple tumor types. Hum Mol Genet 3:813-816.
4. Caspari R, Friedl W, Mandl M, Möslem M, Knapp M, Jacobasch K-H, Ecker K-W, Kreißler-Haag D, Timmermanns G, Propping P (1994): Familial adenomatous polyposis: Mutation at codon 1309 and early onset of colon cancer. Lancet 343:629-632.
5. Caspari R, Olschwang S, Friedl W, Mandl M, Boisson C, Böker T, Augustin A, Kadmon M, Möslein G, Thomas G, Propping P (1995): Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 4:337-340.
6. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, Green J, Hsia YE, Lamiell J, Li H, Wei MH, Schmidt L, Tory K, Kuzmin I, Stackhouse T, Latif F, Linehan WM, Lerman M, Zbar B (1995): Germline mutations in the von Hippie-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutation 5:66-75.
7. Consensus Development Panel (CDP) (1994): National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11-13, 1991. Arch Neurol 51:201-207.
8. Dryja TP, Rapaport J, McGee TL, Nork TM, Schwartz TL (1993): Molecular etiology of low-penetrance retinoblastoma in two pedigrees. Am J Hum Genet 52:1122-1128.
9. Easton DF, Ponder MA, Huson SM, Ponder BAJ (1993): An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 53:305-313.
10. Evans DGR, Huson SM, Donnai D, Neary W, Blair V, Teare D, Newton V, Strachan T, Ramsden R, Harris R (1992a): A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness and confirmation of maternal transmission effect on severity. J Med Genet 29:841-846.
11. Evans DGR, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992b): A clinical study of type 2 neurofibromatosis. Quart J Med 84:603-618.
12. Human Gene Mapping 11 (1991): Eleventh International Conference on Human Gene Mapping, London, U.K., August 18-22, 1991. Cytogenet Cell Genet 58:1864-1865.
13. Kaiser-Kupfer MI, Freidlin V, Datiles MB, Edwards PA, Sherman JL, Parry D, McCain LM, Eldridge R (1989): The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol 107: 541-544.
14. Kanter WR, Eldridge R (1978): Evidence of a maternal effect in central neurofibromatosis. Lancet 2:903.
15. Kanter WR, Eldridge R, Fabricant R, Allen JC, Koerber T (1980): Central neurofibromatosis with bilateral acoustic neuroma: Genetic, clinical and biochemical distinction from peripheral neurofibromatosis. Neurology 30:851-859.
16. Kayes LM, Burke W, Riccardi VM, Bennett R, Ehrlich P, Rubenstein A, Stephens K (1994): Deletions spanning the neurofibromatosis 1 gene: Identification and phenotype of five patients. Am J Hum Genet 54:424-436.
17. Kluwe L, Pulst SM, Kop̈pen J, Mautner VF (1995): A 163-bp deletion at the C-terminus of the schwannomin gene associated with variable phenotypes of neurofibromatosis type 2. Hum Genet 95: 443-446.
18. Liu JL (1990): A genetic and clinical study of retinoblastoma in twins [Chinese]. Chung-Hua Yen Ko Tsa Chih [Chinese Journal of Ophthalmology] 26:360-363.
19. Lohmann DR, Brandt B, Hopping W, Passarge E, Horsthemke B (1994): Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum Genet 94:349-354.
20. Mérel P, Hoang-Xuan K, Sanson M, Bijlsma E, Rouleau G, Laurent-Pulg P, Pulst S, Baser M, Lenoir G, Sterkers MJ, Philippon J, Resche F, Mautner VF, Fischer G, Hulsebos T, Aurias A, Delattre O, Thomas G (1995): Screening for germ-line mutations in the NF2 gene. Genes Chromosomes Cancer 12:117-127.
21. Nagase H, Miyoshi Y, Horii A, Aoki T, Ogawa M, Utsunomiya J, Baba S, Sasazuki T, Nakamura Y (1993): Correlation between the location of germ-line mutations in the APC gene and the number of colorectal polyps in familial adenomatous polyposis patients. Cancer Res 52:4055-4057.
22. Olschwang S, Tiret A, Laurent-Pulg P, Muleris M, Pare R, Thomas G (1993): Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 75:959-968.
23. Onadim Z, Hogg A, Baird PN, Cowell JK (1992): Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype. Proc Natl Acad Sci (USA) 89:6177-6181.
24. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N (1994): Neurofibromatosis 2 (NF2): Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52:450-461.
25. Parry DM, Kaiser-Kupfer MI, Sherman JL, Pikus A, Eldridge R (1991): Neurofibromatosis 2 (bilateral acoustic or central neurofibromatosis), a treatable cause of deafness. Ann NY Acad Sci 630: 305-307.
26. Polymeropoulos MH, Xiao H, Rath DS, Merril CR (1991a): Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). Nucleic Acids Res 19:3753.
27. Polymeropoulos MH, Xiao H, Rath DS, Merril CR (1991b): Tetranucleotide repeat polymorphism at the human aromatase cytochrome P-450 gene (CYP19). Nucleic Acids Res 19:4018.
28. Ragge NK, Baser ME, Klein J, Nechiporuk A, Sainz J, Pulst S-M, Riccardi VM (1995): Ocular abnormalities in neurofibromatosis 2. Am J Ophthalmol 120:634-641.
29. Riccardi VM (1993): Genotype, malleotype, phenotype, and randomness: Lessons from neurofibromatosis-1 (NF-1). Am J Hum Genet 53:301-304.
30. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, De Jong P, Parry D, Eldridge R, Aurias A, Delattre O, Thomas G (1993): Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 363:515-521.
31. Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja TP (1991): Oncogenic germ-line mutations in SP1 and ATF sites in the human retinoblastoma gene. Nature 353:83-86.
32. Sainio M, Strachan T, Blomstedt G, Olonen O, Setälä K, Palotie A, Palo J, Pyykkö I, Peltonen L, Jääskeläinen J (1995): Presymptomatic DNA and MRI diagnosis of neurofibromatosis 2 with mild clinical course in an extended pedigree. Neurology 45:1314-1322.
33. Sainz J, Nechiporuk A, Kim U-J, Simon MI, Pulst SM (1993): CA-repeat polymorphism at the D22S430 locus adjacent to NF2. Hum Mol Genet 2:2203.
34. Sanson M, Marineau C, Desmaze C, Lutchman M, Ruttledge M Baron C, Narod S, Delattre O, Gilbert G, Thomas G, Aurias A, Rouleau GA (1993): Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus. Hum Mol Genet 2:1215-1220.
35. Scoles D, Baser ME, Pulst SM (1996): A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes. Neurology (in press).
36. Spirio L, Olschwang S, Groden J, Robertson M, Samowitz W, Joslyn G, Gelbert L, Thliveris A, Carlson M, Otterud B, Lynch H, Watson P, Lynch P, Laurent-Pulg P, Burt R, Hughes JP, Thomas G, Leppert M, White R (1993): Alleles of the APC gene: An attenuated form of familial polyposis. Cell 75:951-957.
37. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF (1993): A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800.
38. Wallis YL, Macdonald F, Hultén, Morton JEV, McKeown CM, Neoptolemos JP, Keighley M, Morton DG (1994): Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis. Hum Genet 94:543-548.
39. Watson CJ, Gaunt L, Evans G, Patel K, Harris R, Strachan T (1993): A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus. Hum Mol Genet 2:701-704.
40. Weissenbach J, Gyapay G, Dib C, Dib C, Vignal A, Morissette J, Millaseau P, Vaysseix G, Lathrop M (1992): A second-generation map of the human genome. Nature 359:794-801.
41. Wertelecki W, Rouleau GA, Superneau DW, Forehand LW, Williams JP, Haines JL, Gusella JF (1988): Neurofibromatosis 2: Clinical and DNA linkage studies of a large kindred. New Engl J Med 319:278-283.
42. Wishart JH (1822): Case of tumours in the skull, dura mater, and brain. Edinburgh Med Surg J 18:393-397.